Prokupets Elena's Form 4 filing
C4 Therapeutics, Inc.CCCC · filed Sep 24, 2021
- Accession no.
- 0001209191-21-057633
- Filed
- Sep 24, 2021
- Trade date
- Sep 22-24, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $1.65M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prokupets ElenaCIK 0001824823 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2021 | Common Stock | SSaleDisposed | −3,544 | $50.10F2 | −$177,554.4 | 39,492 | Indirect | |
| Sep 22, 2021 | Common Stock | SSaleDisposed | −7,004 | $50.09F4 | −$350,830.36 | 519,360 | Indirect | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −5,926 | $50.35F6 | −$298,374.1 | 33,566 | Indirect | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −446 | $51.09F7 | −$22,786.14 | 33,120 | Indirect | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −11,801 | $50.35F6 | −$594,180.35 | 507,559 | Indirect | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −1,007 | $51.08F8 | −$51,437.56 | 506,552 | Indirect | |
| Sep 24, 2021 | Common Stock | SSaleDisposed | −900 | $50.11F9 | −$45,099 | 32,220 | Indirect | |
| Sep 24, 2021 | Common Stock | SSaleDisposed | −2,115 | $50.10F4 | −$105,961.5 | 504,437 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.31. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 2 transactions in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 2 transactions in Table I.
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.04 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.